Brackmann Christoph — SEC Form 4 filings

SEC reporting owner CIK 2048634. 4 Form 4 filings on record with FilingPulse; latest filed 2026-03-05.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2025-03-06 to 2026-03-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NovoCure Ltd (NVCR)Chief Financial Officer43 legs · 20,000 sh · $231,8001 leg · 6,412 sh · $85,3145

Form 4 filings — Brackmann Christoph

FiledFormIssuerReported transactionsSource
2026-03-054NovoCure Ltd (NVCR)Grant/award (A): 55,137 @ $0 · Sale (S): 6,412 @ $13.31 · Grant/award (A): 80,674 (derivative) @ $0EDGAR
2025-11-044NovoCure Ltd (NVCR)Tax withholding (F): 7,033 @ $12.23EDGAR
2025-07-304NovoCure Ltd (NVCR)Purchase (P): 10,000 @ $11.63 · Purchase (P): 5,000 @ $11.60 · Purchase (P): 5,000 @ $11.50EDGAR
2025-03-064NovoCure Ltd (NVCR)Grant/award (A): 54,975 @ $18.19 · Grant/award (A): 81,499 (derivative) @ $18.19EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2048634 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →